Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
T-Lymphocytes, Regulatory | 20 | 2024 | 3080 | 3.170 |
Why?
|
Graft Rejection | 34 | 2024 | 4446 | 2.870 |
Why?
|
Kidney Transplantation | 26 | 2024 | 4235 | 2.650 |
Why?
|
Immunosuppressive Agents | 16 | 2023 | 4176 | 1.900 |
Why?
|
Organ Transplantation | 9 | 2024 | 1157 | 1.770 |
Why?
|
Graft Survival | 17 | 2023 | 3820 | 1.630 |
Why?
|
Heart Transplantation | 12 | 2021 | 3233 | 1.360 |
Why?
|
Isoantibodies | 6 | 2023 | 674 | 1.240 |
Why?
|
Granzymes | 5 | 2022 | 277 | 1.220 |
Why?
|
Serpins | 5 | 2017 | 247 | 1.110 |
Why?
|
Cyclosporine | 3 | 2016 | 778 | 1.100 |
Why?
|
Proteasome Endopeptidase Complex | 4 | 2023 | 1321 | 0.940 |
Why?
|
T-Lymphocytes, Helper-Inducer | 3 | 2020 | 974 | 0.800 |
Why?
|
Hair Follicle | 1 | 2024 | 211 | 0.800 |
Why?
|
Immunologic Factors | 3 | 2024 | 1590 | 0.710 |
Why?
|
Class Ib Phosphatidylinositol 3-Kinase | 2 | 2017 | 43 | 0.690 |
Why?
|
Alopecia | 1 | 2024 | 412 | 0.670 |
Why?
|
Transplantation Tolerance | 6 | 2024 | 605 | 0.660 |
Why?
|
Opportunistic Infections | 2 | 2020 | 376 | 0.600 |
Why?
|
Interleukin-2 | 2 | 2024 | 1889 | 0.590 |
Why?
|
BK Virus | 1 | 2017 | 123 | 0.530 |
Why?
|
Polyomavirus Infections | 2 | 2020 | 194 | 0.520 |
Why?
|
Renal Insufficiency | 1 | 2022 | 809 | 0.520 |
Why?
|
Organ Preservation | 1 | 2019 | 382 | 0.510 |
Why?
|
Tumor Virus Infections | 2 | 2020 | 438 | 0.500 |
Why?
|
Cytokines | 10 | 2021 | 7396 | 0.490 |
Why?
|
Diabetes Mellitus, Type 1 | 5 | 2017 | 3415 | 0.490 |
Why?
|
Mice, Inbred BALB C | 13 | 2020 | 6214 | 0.480 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2024 | 1349 | 0.470 |
Why?
|
Quinoxalines | 2 | 2017 | 296 | 0.460 |
Why?
|
Copepoda | 1 | 2014 | 14 | 0.460 |
Why?
|
Luciferases, Firefly | 1 | 2014 | 37 | 0.460 |
Why?
|
Dendritic Cells | 10 | 2018 | 2747 | 0.450 |
Why?
|
Receptors, Antigen, T-Cell | 6 | 2024 | 2547 | 0.450 |
Why?
|
Immune Tolerance | 7 | 2024 | 2302 | 0.440 |
Why?
|
Thiazolidinediones | 2 | 2017 | 461 | 0.430 |
Why?
|
Skin Transplantation | 2 | 2017 | 1083 | 0.430 |
Why?
|
Immunity, Humoral | 1 | 2017 | 606 | 0.420 |
Why?
|
Polyesters | 2 | 2016 | 373 | 0.420 |
Why?
|
Exosomes | 1 | 2017 | 424 | 0.420 |
Why?
|
Immunity, Cellular | 2 | 2022 | 1560 | 0.410 |
Why?
|
Steroids | 2 | 2014 | 929 | 0.410 |
Why?
|
Membrane Proteins | 5 | 2021 | 7859 | 0.410 |
Why?
|
Luminescent Measurements | 1 | 2014 | 342 | 0.400 |
Why?
|
Antigen Presentation | 1 | 2017 | 1251 | 0.390 |
Why?
|
Mice | 33 | 2024 | 81539 | 0.390 |
Why?
|
Cytomegalovirus Infections | 2 | 2020 | 831 | 0.390 |
Why?
|
Animals | 44 | 2024 | 168475 | 0.390 |
Why?
|
Immunologic Memory | 2 | 2016 | 1359 | 0.380 |
Why?
|
Biosensing Techniques | 1 | 2017 | 650 | 0.380 |
Why?
|
Autoimmunity | 2 | 2017 | 1356 | 0.380 |
Why?
|
Serine Endopeptidases | 2 | 2013 | 1023 | 0.360 |
Why?
|
Alkaline Phosphatase | 1 | 2014 | 864 | 0.360 |
Why?
|
CD8-Positive T-Lymphocytes | 5 | 2024 | 4580 | 0.350 |
Why?
|
Apoptosis | 3 | 2022 | 9490 | 0.350 |
Why?
|
T-Lymphocytes | 13 | 2021 | 10194 | 0.350 |
Why?
|
Tacrolimus | 4 | 2018 | 733 | 0.330 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2024 | 1784 | 0.330 |
Why?
|
Islets of Langerhans Transplantation | 2 | 2015 | 740 | 0.320 |
Why?
|
Bone Marrow | 2 | 2017 | 2911 | 0.310 |
Why?
|
Lymph Nodes | 2 | 2018 | 3465 | 0.300 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2017 | 2057 | 0.300 |
Why?
|
Autoimmune Diseases | 2 | 2018 | 2244 | 0.300 |
Why?
|
Transplantation, Homologous | 7 | 2023 | 4807 | 0.300 |
Why?
|
Mice, Inbred C57BL | 13 | 2020 | 22174 | 0.300 |
Why?
|
Kidney | 6 | 2023 | 7048 | 0.280 |
Why?
|
Molecular Imaging | 1 | 2014 | 815 | 0.280 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 2 | 2020 | 179 | 0.270 |
Why?
|
Multiple Myeloma | 4 | 2020 | 5146 | 0.260 |
Why?
|
Cell Proliferation | 7 | 2018 | 10451 | 0.250 |
Why?
|
Immunotherapy | 2 | 2018 | 4652 | 0.250 |
Why?
|
Humans | 61 | 2024 | 761596 | 0.250 |
Why?
|
Asparagine | 2 | 2023 | 119 | 0.250 |
Why?
|
Graft vs Host Disease | 2 | 2015 | 3029 | 0.240 |
Why?
|
Nanoparticles | 3 | 2018 | 1958 | 0.240 |
Why?
|
Interferon-gamma | 4 | 2024 | 3162 | 0.240 |
Why?
|
Immunoconjugates | 1 | 2012 | 953 | 0.240 |
Why?
|
Drug Delivery Systems | 1 | 2016 | 2226 | 0.240 |
Why?
|
Insulin-Secreting Cells | 1 | 2012 | 901 | 0.230 |
Why?
|
Pandemics | 3 | 2020 | 8656 | 0.230 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2017 | 4369 | 0.230 |
Why?
|
Drug Carriers | 2 | 2018 | 706 | 0.230 |
Why?
|
Kidney Failure, Chronic | 1 | 2016 | 2472 | 0.220 |
Why?
|
Focal Adhesions | 1 | 2023 | 115 | 0.210 |
Why?
|
Mice, Inbred NOD | 4 | 2017 | 1827 | 0.210 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5841 | 0.200 |
Why?
|
Lymphocyte Activation | 4 | 2017 | 5485 | 0.200 |
Why?
|
Homeostasis | 1 | 2013 | 3323 | 0.200 |
Why?
|
Immunocompromised Host | 3 | 2024 | 858 | 0.190 |
Why?
|
Leukocytes, Mononuclear | 4 | 2023 | 1844 | 0.190 |
Why?
|
Inflammation | 4 | 2021 | 10774 | 0.190 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2021 | 15936 | 0.190 |
Why?
|
Chemokine CXCL9 | 2 | 2020 | 135 | 0.190 |
Why?
|
Immunophenotyping | 2 | 2017 | 1869 | 0.190 |
Why?
|
Needles | 1 | 2024 | 451 | 0.180 |
Why?
|
Monitoring, Physiologic | 2 | 2022 | 1779 | 0.180 |
Why?
|
Drug Therapy, Combination | 3 | 2017 | 6312 | 0.180 |
Why?
|
Mice, Knockout | 10 | 2024 | 14417 | 0.180 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 5672 | 0.180 |
Why?
|
Boron | 1 | 2020 | 37 | 0.180 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 7391 | 0.170 |
Why?
|
Withholding Treatment | 2 | 2014 | 617 | 0.170 |
Why?
|
Antibodies, Viral | 4 | 2024 | 3156 | 0.170 |
Why?
|
Alloys | 1 | 2020 | 110 | 0.170 |
Why?
|
Interleukin-10 | 2 | 2022 | 1175 | 0.170 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 2023 | 335 | 0.170 |
Why?
|
Silver | 1 | 2020 | 117 | 0.170 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2021 | 618 | 0.160 |
Why?
|
Postoperative Complications | 3 | 2020 | 15633 | 0.160 |
Why?
|
Intracellular Space | 1 | 2020 | 197 | 0.160 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2014 | 1351 | 0.160 |
Why?
|
Mesenchymal Stem Cells | 4 | 2015 | 1642 | 0.160 |
Why?
|
Renal Artery Obstruction | 1 | 2020 | 219 | 0.160 |
Why?
|
Hydrogels | 1 | 2024 | 720 | 0.160 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2017 | 2865 | 0.150 |
Why?
|
Hyaluronic Acid | 1 | 2021 | 483 | 0.150 |
Why?
|
Integrin alpha Chains | 1 | 2018 | 95 | 0.150 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2018 | 694 | 0.150 |
Why?
|
Transplants | 1 | 2020 | 206 | 0.150 |
Why?
|
Receptor, Interferon alpha-beta | 1 | 2018 | 112 | 0.150 |
Why?
|
Mesenchymal Stem Cell Transplantation | 2 | 2015 | 499 | 0.150 |
Why?
|
Isoantigens | 1 | 2020 | 551 | 0.150 |
Why?
|
Aneurysm, False | 1 | 2020 | 255 | 0.140 |
Why?
|
Copper | 1 | 2020 | 369 | 0.140 |
Why?
|
Disease Models, Animal | 6 | 2021 | 18255 | 0.140 |
Why?
|
Histocompatibility Testing | 1 | 2018 | 712 | 0.140 |
Why?
|
Pathology, Molecular | 1 | 2020 | 328 | 0.140 |
Why?
|
Microspheres | 2 | 2019 | 784 | 0.140 |
Why?
|
Cell Transplantation | 1 | 2018 | 472 | 0.140 |
Why?
|
Tissue Donors | 2 | 2020 | 2332 | 0.140 |
Why?
|
Chemokine CXCL10 | 1 | 2017 | 316 | 0.130 |
Why?
|
Receptor, Notch1 | 1 | 2019 | 496 | 0.130 |
Why?
|
Cell Survival | 2 | 2017 | 5791 | 0.130 |
Why?
|
Metal Nanoparticles | 1 | 2020 | 399 | 0.130 |
Why?
|
Hep G2 Cells | 1 | 2016 | 379 | 0.130 |
Why?
|
Flow Cytometry | 5 | 2013 | 5870 | 0.130 |
Why?
|
Clinical Trials as Topic | 3 | 2020 | 8002 | 0.130 |
Why?
|
Myeloid Cells | 1 | 2020 | 823 | 0.130 |
Why?
|
Adaptive Immunity | 1 | 2020 | 726 | 0.120 |
Why?
|
Neoplasm Transplantation | 2 | 2016 | 2016 | 0.120 |
Why?
|
Caspase 3 | 1 | 2017 | 731 | 0.120 |
Why?
|
Time Factors | 8 | 2017 | 39969 | 0.120 |
Why?
|
Peptides | 3 | 2024 | 4358 | 0.120 |
Why?
|
Antibodies, Neutralizing | 1 | 2024 | 1943 | 0.120 |
Why?
|
Point Mutation | 1 | 2020 | 1595 | 0.120 |
Why?
|
Heterocyclic Compounds | 1 | 2015 | 246 | 0.120 |
Why?
|
Perfusion | 1 | 2019 | 1373 | 0.120 |
Why?
|
Killer Cells, Natural | 4 | 2018 | 2201 | 0.120 |
Why?
|
Interleukin-6 | 2 | 2022 | 3208 | 0.110 |
Why?
|
HLA Antigens | 2 | 2023 | 1328 | 0.110 |
Why?
|
Fluorocarbons | 1 | 2019 | 492 | 0.110 |
Why?
|
Precursor Cells, T-Lymphoid | 1 | 2014 | 19 | 0.110 |
Why?
|
T-Lymphocyte Subsets | 2 | 2019 | 1802 | 0.110 |
Why?
|
International Cooperation | 1 | 2020 | 1422 | 0.110 |
Why?
|
Immunotherapy, Adoptive | 1 | 2023 | 1469 | 0.110 |
Why?
|
STAT1 Transcription Factor | 1 | 2015 | 341 | 0.110 |
Why?
|
Spleen | 3 | 2018 | 2295 | 0.110 |
Why?
|
Facial Transplantation | 1 | 2016 | 221 | 0.110 |
Why?
|
Histocompatibility | 1 | 2014 | 317 | 0.110 |
Why?
|
Neoplasms, Experimental | 1 | 2018 | 1229 | 0.100 |
Why?
|
Calcineurin | 1 | 2013 | 229 | 0.100 |
Why?
|
Antibodies | 2 | 2022 | 2418 | 0.100 |
Why?
|
Antilymphocyte Serum | 1 | 2014 | 487 | 0.100 |
Why?
|
Signal Transduction | 5 | 2020 | 23447 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3086 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3206 | 0.100 |
Why?
|
Phagocytosis | 1 | 2018 | 1528 | 0.100 |
Why?
|
Lung Transplantation | 1 | 2021 | 1310 | 0.100 |
Why?
|
Organometallic Compounds | 1 | 2015 | 647 | 0.100 |
Why?
|
B-Lymphocytes | 3 | 2022 | 4758 | 0.100 |
Why?
|
Liposomes | 1 | 2015 | 783 | 0.100 |
Why?
|
Bone Marrow Cells | 3 | 2015 | 2417 | 0.100 |
Why?
|
Antigens, Surface | 1 | 2016 | 1606 | 0.100 |
Why?
|
Staphylococcus aureus | 1 | 2020 | 1457 | 0.100 |
Why?
|
Ultrasonography, Interventional | 1 | 2019 | 1496 | 0.090 |
Why?
|
Complement System Proteins | 1 | 2014 | 735 | 0.090 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3415 | 0.090 |
Why?
|
Th1 Cells | 1 | 2016 | 1036 | 0.090 |
Why?
|
Lentivirus | 1 | 2014 | 508 | 0.090 |
Why?
|
Cell Line, Tumor | 5 | 2018 | 16990 | 0.090 |
Why?
|
Autoantigens | 2 | 2012 | 891 | 0.090 |
Why?
|
Tumor Microenvironment | 3 | 2020 | 3878 | 0.090 |
Why?
|
Rodentia | 1 | 2012 | 262 | 0.090 |
Why?
|
Endothelial Cells | 1 | 2023 | 3549 | 0.090 |
Why?
|
Interleukin-17 | 1 | 2016 | 912 | 0.090 |
Why?
|
Pancreas | 1 | 2017 | 1691 | 0.080 |
Why?
|
Antigens, CD | 2 | 2018 | 4001 | 0.080 |
Why?
|
Lymphocytes | 1 | 2017 | 2612 | 0.080 |
Why?
|
STAT5 Transcription Factor | 2 | 2021 | 265 | 0.080 |
Why?
|
Bone and Bones | 1 | 2020 | 2568 | 0.080 |
Why?
|
Glomerulonephritis | 1 | 2011 | 331 | 0.080 |
Why?
|
Kidney Diseases | 3 | 2020 | 2091 | 0.080 |
Why?
|
Sirolimus | 1 | 2016 | 1533 | 0.080 |
Why?
|
Kidney Glomerulus | 1 | 2011 | 568 | 0.080 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2018 | 1899 | 0.080 |
Why?
|
Desensitization, Immunologic | 1 | 2014 | 556 | 0.080 |
Why?
|
Meta-Analysis as Topic | 1 | 2013 | 1380 | 0.080 |
Why?
|
Multicenter Studies as Topic | 1 | 2013 | 1702 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2017 | 10212 | 0.080 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2013 | 1334 | 0.080 |
Why?
|
Up-Regulation | 2 | 2015 | 4125 | 0.080 |
Why?
|
Mice, Transgenic | 3 | 2019 | 9542 | 0.080 |
Why?
|
Societies, Medical | 1 | 2020 | 3905 | 0.080 |
Why?
|
Antibodies, Blocking | 2 | 2019 | 243 | 0.080 |
Why?
|
Immunity, Innate | 1 | 2020 | 3066 | 0.080 |
Why?
|
Male | 12 | 2024 | 360846 | 0.070 |
Why?
|
Patient Selection | 1 | 2020 | 4244 | 0.070 |
Why?
|
Gene Expression | 2 | 2017 | 7581 | 0.070 |
Why?
|
History, 21st Century | 1 | 2013 | 1567 | 0.070 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 1971 | 0.070 |
Why?
|
Immunoassay | 1 | 2011 | 745 | 0.070 |
Why?
|
Immune Evasion | 1 | 2010 | 363 | 0.070 |
Why?
|
Myocardium | 1 | 2020 | 4725 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2014 | 2457 | 0.070 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2023 | 1435 | 0.070 |
Why?
|
Risk Assessment | 2 | 2018 | 23996 | 0.070 |
Why?
|
Forkhead Transcription Factors | 1 | 2014 | 1616 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 3810 | 0.070 |
Why?
|
Female | 12 | 2024 | 392705 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3617 | 0.060 |
Why?
|
History, 20th Century | 1 | 2013 | 2767 | 0.060 |
Why?
|
Gene Expression Regulation | 4 | 2021 | 11904 | 0.060 |
Why?
|
Oxidative Stress | 2 | 2014 | 3113 | 0.060 |
Why?
|
Liver Transplantation | 2 | 2024 | 2330 | 0.060 |
Why?
|
Macrophages | 2 | 2018 | 5767 | 0.060 |
Why?
|
Antibodies, Monoclonal | 2 | 2022 | 9177 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2018 | 64685 | 0.060 |
Why?
|
Odds Ratio | 1 | 2017 | 9647 | 0.060 |
Why?
|
Renin-Angiotensin System | 1 | 2009 | 737 | 0.060 |
Why?
|
Forecasting | 1 | 2013 | 2928 | 0.060 |
Why?
|
HEK293 Cells | 1 | 2014 | 4281 | 0.060 |
Why?
|
Cell Differentiation | 4 | 2015 | 11530 | 0.060 |
Why?
|
Proteomics | 1 | 2017 | 3848 | 0.060 |
Why?
|
Leukocytes | 1 | 2012 | 2026 | 0.060 |
Why?
|
Middle Aged | 9 | 2024 | 220921 | 0.050 |
Why?
|
Hyperglycemia | 1 | 2012 | 1376 | 0.050 |
Why?
|
Antioxidants | 1 | 2010 | 1668 | 0.050 |
Why?
|
STAT3 Transcription Factor | 2 | 2018 | 871 | 0.050 |
Why?
|
HLA-DQ Antigens | 1 | 2023 | 191 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5672 | 0.050 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2017 | 899 | 0.050 |
Why?
|
Cell Movement | 1 | 2014 | 5205 | 0.050 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2022 | 123 | 0.050 |
Why?
|
Genomics | 1 | 2017 | 5821 | 0.050 |
Why?
|
Inflammation Mediators | 1 | 2010 | 1886 | 0.050 |
Why?
|
Vaccination | 2 | 2024 | 3384 | 0.050 |
Why?
|
Phosphorylation | 1 | 2012 | 8321 | 0.050 |
Why?
|
Glioma | 1 | 2015 | 3455 | 0.040 |
Why?
|
Risk Factors | 5 | 2022 | 74213 | 0.040 |
Why?
|
Adult | 6 | 2024 | 221210 | 0.040 |
Why?
|
Membrane Glycoproteins | 1 | 2011 | 3701 | 0.040 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2021 | 306 | 0.040 |
Why?
|
Gene Knockdown Techniques | 2 | 2017 | 1612 | 0.040 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2022 | 545 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 616 | 0.040 |
Why?
|
Polyomavirus | 1 | 2020 | 234 | 0.040 |
Why?
|
Endothelium, Vascular | 1 | 2011 | 4431 | 0.040 |
Why?
|
Incidence | 1 | 2017 | 21355 | 0.040 |
Why?
|
Lymphotoxin-alpha | 1 | 2018 | 93 | 0.040 |
Why?
|
Renal Artery | 1 | 2020 | 351 | 0.040 |
Why?
|
Immunoenzyme Techniques | 2 | 2011 | 1704 | 0.040 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2018 | 151 | 0.040 |
Why?
|
Oxides | 1 | 2019 | 401 | 0.040 |
Why?
|
Survival Analysis | 2 | 2021 | 10090 | 0.040 |
Why?
|
Ferric Compounds | 1 | 2019 | 378 | 0.040 |
Why?
|
Antibody Formation | 1 | 2022 | 1395 | 0.040 |
Why?
|
Hormones | 1 | 2021 | 869 | 0.040 |
Why?
|
Structure-Activity Relationship | 1 | 2023 | 3076 | 0.040 |
Why?
|
Static Electricity | 1 | 2017 | 261 | 0.040 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2018 | 303 | 0.030 |
Why?
|
Plasma Cells | 1 | 2020 | 599 | 0.030 |
Why?
|
Antibodies, Neoplasm | 1 | 2018 | 281 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2016 | 5821 | 0.030 |
Why?
|
Streptavidin | 1 | 2015 | 82 | 0.030 |
Why?
|
Endocytosis | 1 | 2020 | 957 | 0.030 |
Why?
|
Cytomegalovirus | 1 | 2020 | 756 | 0.030 |
Why?
|
Bone Marrow Transplantation | 2 | 2015 | 2693 | 0.030 |
Why?
|
Rhodamines | 1 | 2015 | 178 | 0.030 |
Why?
|
Cadherins | 1 | 2020 | 903 | 0.030 |
Why?
|
Kinetics | 1 | 2023 | 6374 | 0.030 |
Why?
|
Cell Line | 2 | 2020 | 15601 | 0.030 |
Why?
|
Biotin | 1 | 2015 | 253 | 0.030 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 2015 | 509 | 0.030 |
Why?
|
Osteoblasts | 1 | 2020 | 1143 | 0.030 |
Why?
|
Contrast Media | 2 | 2019 | 5307 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2018 | 10766 | 0.030 |
Why?
|
Neoplasms | 3 | 2018 | 22173 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2015 | 9032 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 2015 | 681 | 0.030 |
Why?
|
Protein Subunits | 1 | 2017 | 943 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2016 | 679 | 0.030 |
Why?
|
Plasmapheresis | 1 | 2014 | 206 | 0.030 |
Why?
|
Cryoelectron Microscopy | 1 | 2017 | 650 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 1 | 2020 | 1936 | 0.030 |
Why?
|
Lipid Bilayers | 1 | 2015 | 383 | 0.030 |
Why?
|
DNA, Viral | 1 | 2020 | 2202 | 0.030 |
Why?
|
Quality of Life | 1 | 2014 | 13367 | 0.030 |
Why?
|
Gadolinium DTPA | 1 | 2015 | 823 | 0.030 |
Why?
|
Mycophenolic Acid | 1 | 2014 | 349 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2020 | 2021 | 0.020 |
Why?
|
Antipyrine | 1 | 2010 | 40 | 0.020 |
Why?
|
Models, Animal | 1 | 2017 | 2112 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-cbl | 1 | 2011 | 120 | 0.020 |
Why?
|
Iron | 1 | 2019 | 1793 | 0.020 |
Why?
|
Fas Ligand Protein | 1 | 2011 | 216 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2015 | 2065 | 0.020 |
Why?
|
Free Radical Scavengers | 1 | 2010 | 211 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2019 | 18966 | 0.020 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2011 | 263 | 0.020 |
Why?
|
Acute-Phase Proteins | 1 | 2011 | 250 | 0.020 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2014 | 664 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2011 | 410 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 3605 | 0.020 |
Why?
|
Living Donors | 1 | 2014 | 641 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2013 | 12149 | 0.020 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2010 | 175 | 0.020 |
Why?
|
Mice, Nude | 1 | 2015 | 3614 | 0.020 |
Why?
|
Lymphoid Tissue | 1 | 2010 | 445 | 0.020 |
Why?
|
Temperature | 1 | 2015 | 2226 | 0.020 |
Why?
|
Binding Sites | 1 | 2017 | 6056 | 0.020 |
Why?
|
Th17 Cells | 1 | 2015 | 794 | 0.020 |
Why?
|
Aged | 4 | 2024 | 169310 | 0.020 |
Why?
|
Primary Graft Dysfunction | 1 | 2009 | 111 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 36426 | 0.020 |
Why?
|
Capillaries | 1 | 2011 | 755 | 0.020 |
Why?
|
Rabbits | 1 | 2014 | 4772 | 0.020 |
Why?
|
Down-Regulation | 1 | 2015 | 2919 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2023 | 80647 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 54423 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6766 | 0.020 |
Why?
|
Models, Molecular | 1 | 2017 | 5439 | 0.020 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2009 | 362 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2016 | 2178 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2018 | 2986 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 2467 | 0.020 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2009 | 662 | 0.020 |
Why?
|
Angiotensin II | 1 | 2009 | 849 | 0.020 |
Why?
|
Communicable Diseases | 1 | 2014 | 875 | 0.020 |
Why?
|
Cell Separation | 1 | 2011 | 1720 | 0.020 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2009 | 629 | 0.020 |
Why?
|
Mice, SCID | 1 | 2010 | 2626 | 0.020 |
Why?
|
NF-kappa B | 1 | 2014 | 2490 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 9420 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2011 | 999 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2020 | 12794 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2016 | 39106 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6484 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18399 | 0.010 |
Why?
|
Protein Binding | 1 | 2015 | 9353 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8527 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9610 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2020 | 7406 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12463 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2014 | 5493 | 0.010 |
Why?
|
Boston | 1 | 2014 | 9327 | 0.010 |
Why?
|
Pilot Projects | 1 | 2014 | 8633 | 0.010 |
Why?
|
Acute Disease | 1 | 2011 | 7237 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2011 | 4352 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2009 | 4243 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2011 | 3397 | 0.010 |
Why?
|
Prognosis | 1 | 2016 | 29629 | 0.010 |
Why?
|
Cohort Studies | 1 | 2016 | 41495 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2011 | 22176 | 0.010 |
Why?
|
Mutation | 1 | 2017 | 30053 | 0.010 |
Why?
|